Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 1
2016 1
2017 3
2018 3
2019 1
2020 3
2021 8
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS.
Cetin Gedik K, Ortega-Villa AM, Materne G, Rastegar A, Montealegre Sanchez GA, Reinhardt A, Brogan PA, Berkun Y, Murias S, Robles M, Schalm S, de Jesus AA, Goldbach-Mansky R. Cetin Gedik K, et al. Among authors: murias s. Ann Rheum Dis. 2024 Apr 30:ard-2023-225463. doi: 10.1136/ard-2023-225463. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38653530 Free article.
What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment.
Murias S, Boteanu A, Calvo I, Nuñez E, Bravo B, Bustabad S, Camacho M, Clemente D, Graña J, de Inocencio J, Lacruz L, Mesa-Del-Castillo P, Nieto-González JC, Pinedo MDC, Quesada E, Vargas C, Antón J. Murias S, et al. Reumatol Clin (Engl Ed). 2023 Jan;19(1):26-33. doi: 10.1016/j.reumae.2022.11.002. Reumatol Clin (Engl Ed). 2023. PMID: 36603964 Free article.
Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study.
Udaondo C, Núñez Cuadros E, Murias S, Remesal A, Alcobendas R, Guerrero C, Guillen-Martin S, Escuredo M, Aleo E, Alonso D, Tagarro A, De Santiago E, Camacho-Lovillo M, Diaz F, Arenas D, Camacho P, Lirola MJ, Díaz Almirón M, Calvo C. Udaondo C, et al. Among authors: murias s. Front Pediatr. 2022 Aug 11;10:917731. doi: 10.3389/fped.2022.917731. eCollection 2022. Front Pediatr. 2022. PMID: 36034561 Free PMC article.
Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study.
Melsens K, Cutolo M, Schonenberg-Meinema D, Foeldvari I, Leone MC, Mostmans Y, Badot V, Cimaz R, Dehoorne J, Deschepper E, Frech T, Hernandez-Zapata J, Ingegnoli F, Khan A, Krasowska D, Lehmann H, Makol A, Mesa-Navas MA, Michalska-Jakubus M, Müller-Ladner U, Nuño-Nuño L, Overbury R, Pizzorni C, Radic M, Ramadoss D, Ravelli A, Rosina S, Udaondo C, van den Berg MJ, Herrick AL, Sulli A, Smith V; EULAR Study Group on Microcirculation in Rheumatic Diseases. Melsens K, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):1605-1615. doi: 10.1093/rheumatology/keac487. Rheumatology (Oxford). 2023. PMID: 36005889 Free PMC article.
Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab.
Koné-Paut I, Piram M, Benseler S, Kuemmerle-Deschner JB, Jansson A, Rosner I, Tommasini A, Murias S, Karadag O, Levy J, McCreddin S, Migliaccio M, De Benedetti F. Koné-Paut I, et al. Among authors: murias s. Joint Bone Spine. 2022 Nov;89(6):105448. doi: 10.1016/j.jbspin.2022.105448. Epub 2022 Aug 6. Joint Bone Spine. 2022. PMID: 35944600 Free article. Clinical Trial.
Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain.
Udaondo C, Millán-Longo C, Permuy C, Valladares L, Falces-Romero I, Muñoz-Gómez C, Morales-Higuera M, Alcobendas R, Remesal A, Murias S, Calvo C. Udaondo C, et al. Among authors: murias s. Clin Rheumatol. 2022 Jun;41(6):1779-1784. doi: 10.1007/s10067-022-06186-z. Epub 2022 Apr 30. Clin Rheumatol. 2022. PMID: 35489011 Free PMC article.
Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial.
Lachmann HJ, Lauwerys B, Miettunen P, Kallinich T, Jansson A, Rosner I, Manna R, Murias S, Savic S, Smeets S, De Benedetti F, Simon A. Lachmann HJ, et al. Among authors: murias s. Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):51-58. doi: 10.55563/clinexprheumatol/e92f7o. Epub 2021 Oct 6. Clin Exp Rheumatol. 2021. PMID: 34622762 Free article. Clinical Trial.
25 results